Tag: Rahul Koul
“AI is reshaping clinical trial design and execution, especially in India”
Dr Saurabh Arora, Managing Director, Auriga Research shares insights on the growing influence of AI in the clinical trials ecosystem; company’s latest partnerships, current activities and future outlook
“Novonesis in India continues to prioritize innovation and customization for local...
Puneeth Kumar KT, Business Director for Planetary Health Biosolutions, Novonesis South Asia shares his exclusive insights on Indian biofuel market trends, his company’s key offerings, ongoing initiatives, and key priorities
Lost in Translation? India’s Biologics R&D Shortfall
Domestic manufacturers have petitioned for tax reliefs—such as income‑tax exemptions on new molecular entities—to incentivize high‑risk R&D
Bridging Science and Business: The Missing Link in Bioscience Innovation
The full potential of bioscience sector can only be realized through a collaborative ecosystem where academia and industry function as complementary forces
“Biomanufacturing has shifted focus from just being efficient to staying ahead...
Sachin Joshi, Managing Director & Founder, PharmNXT Biotech shares insights on the company’s focus on innovation, key product offerings, upcoming initiatives, sustainability and future plans
“Biosimilars set to gain as key biologics lose patents by 2030”
Dr Cyrus Karkaria, President-Biotechnology, Lupin Limited shares his views on the current market trends and growth prospects of Indian biosimilars industry, company’s key offerings, ongoing initiatives, and future plans
“Medtronic invested US$ 510 million in its Hyderabad facility, making it...
Mandeep Singh Kumar, Managing Director and Vice President, Medtronic India shares details on the company’s key milestones, its key offerings, upcoming initiatives, and future plans
FACE TO FACE: Dr Taslimarif Saiyed, Director and CEO, Centre for Cellular...
Taslimarif Saiyed, Director and CEO, Centre for Cellular and Molecular Platforms (C-CAMP) talks about the relevance of Startup Mahakumbh event, key factors driving startup ecosystem, latest trends, challenges and much more.
India’s commendable progress towards being a TB-Free nation
Molecular diagnostic tools, such as CBNAAT and TruNat, have improved the speed and accuracy of TB detection, enabling timely intervention
“We plan to invest more than 1.5 million USD on sustainability...
Shivaji Dashrath Jadhav, Vice President & Head - EHS & Sustainability, Aragen Life Sciences shares insights on his company’s sustainability initiatives and commitment to net zero goals